Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Cypher sirolimus-eluting stent cardiovascular data

A meta-analysis of 38 trials in 18,023 patients showed a similar mortality rate for patients receiving Cypher,

Read the full 177 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE